These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 20363971
1. Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligands. Oberg HH, Ly TT, Ussat S, Meyer T, Kabelitz D, Wesch D. J Immunol; 2010 May 01; 184(9):4733-40. PubMed ID: 20363971 [Abstract] [Full Text] [Related]
2. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs. Bocian K, Borysowski J, Wierzbicki P, Wyzgal J, Klosowska D, Bialoszewska A, Paczek L, Górski A, Korczak-Kowalska G. Nephrol Dial Transplant; 2010 Mar 01; 25(3):710-7. PubMed ID: 19903662 [Abstract] [Full Text] [Related]
3. TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy. Tsai YG, Yang KD, Niu DM, Chien JW, Lin CY. J Immunol; 2010 Jun 15; 184(12):7229-37. PubMed ID: 20483759 [Abstract] [Full Text] [Related]
4. A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25- responder T cells. Benito-Miguel M, García-Carmona Y, Balsa A, Pérez de Ayala C, Cobo-Ibáñez T, Martín-Mola E, Miranda-Carús ME. J Immunol; 2009 Dec 15; 183(12):8268-79. PubMed ID: 20007590 [Abstract] [Full Text] [Related]
5. TLR2 ligands augment cPLA2alpha activity and lead to enhanced leukotriene release in human monocytes. Lindner SC, Köhl U, Maier TJ, Steinhilber D, Sorg BL. J Leukoc Biol; 2009 Aug 15; 86(2):389-99. PubMed ID: 19401382 [Abstract] [Full Text] [Related]
7. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood. Ahn JS, Krishnadas DK, Agrawal B. Int Immunol; 2007 Mar 15; 19(3):227-37. PubMed ID: 17289657 [Abstract] [Full Text] [Related]
8. Regulation of T cell activation by TLR ligands. Oberg HH, Juricke M, Kabelitz D, Wesch D. Eur J Cell Biol; 2011 Mar 15; 90(6-7):582-92. PubMed ID: 21292344 [Abstract] [Full Text] [Related]
9. Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C. Wang JP, Zhang Y, Wei X, Li J, Nan XP, Yu HT, Li Y, Wang PZ, Bai XF. APMIS; 2010 Apr 15; 118(4):261-70. PubMed ID: 20402671 [Abstract] [Full Text] [Related]
10. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Nakata T, Yasuda M, Fujita M, Kataoka H, Kiura K, Sano H, Shibata K. Cell Microbiol; 2006 Dec 15; 8(12):1899-909. PubMed ID: 16848791 [Abstract] [Full Text] [Related]
12. Systemic reduction of functionally suppressive CD4dimCD25highFoxp3+ Tregs in human second trimester pregnancy is induced by progesterone and 17beta-estradiol. Mjösberg J, Svensson J, Johansson E, Hellström L, Casas R, Jenmalm MC, Boij R, Matthiesen L, Jönsson JI, Berg G, Ernerudh J. J Immunol; 2009 Jul 01; 183(1):759-69. PubMed ID: 19535629 [Abstract] [Full Text] [Related]
13. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. Venken K, Thewissen M, Hellings N, Somers V, Hensen K, Rummens JL, Stinissen P. J Immunol Methods; 2007 Apr 30; 322(1-2):1-11. PubMed ID: 17368474 [Abstract] [Full Text] [Related]
14. Ethylene-Diamine-Tetra-Acetate (EDTA) mimics the effect of regulatory T cells in suppression assays: a potential pitfall when using AutoMACS-separated cells. Dige A, Hvas CL, Kelsen J, Deleuran B, Dahlerup JF, Agnholt J. J Immunol Methods; 2010 Feb 28; 353(1-2):141-4. PubMed ID: 19958773 [Abstract] [Full Text] [Related]
15. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C, Zhao Y. Transpl Immunol; 2007 Apr 28; 17(3):153-61. PubMed ID: 17331841 [Abstract] [Full Text] [Related]
16. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. Tsaknaridis L, Spencer L, Culbertson N, Hicks K, LaTocha D, Chou YK, Whitham RH, Bakke A, Jones RE, Offner H, Bourdette DN, Vandenbark AA. J Neurosci Res; 2003 Oct 15; 74(2):296-308. PubMed ID: 14515359 [Abstract] [Full Text] [Related]
17. In vivo anti- and pro-tumour activities of the TLR2 ligand FSL-1. Kiura K, Hasebe A, Saeki A, Segawa T, Okada F, Shamsul HM, Ohtani M, Into T, Inoue N, Wakita M, Shibata K. Immunobiology; 2011 Aug 15; 216(8):891-900. PubMed ID: 21496943 [Abstract] [Full Text] [Related]
18. De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid. Wang J, Huizinga TW, Toes RE. J Immunol; 2009 Sep 15; 183(6):4119-26. PubMed ID: 19717521 [Abstract] [Full Text] [Related]
19. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis. Zhang Y, Wang HB, Chi LJ, Wang WZ. Immunol Lett; 2009 Jan 29; 122(1):52-7. PubMed ID: 19111574 [Abstract] [Full Text] [Related]
20. CD4-mediated functional activation of human CD4+CD25+ regulatory T cells. Becker C, Kubach J, Wijdenes J, Knop J, Jonuleit H. Eur J Immunol; 2007 May 29; 37(5):1217-23. PubMed ID: 17407195 [Abstract] [Full Text] [Related] Page: [Next] [New Search]